Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Authors:
- Paul R. SleathPSPaul R. Sleath
- Jeffrey N. FitznerJFJeffrey N. Fitzner
- Douglas Pat CerrettiDCDouglas Pat Cerretti
- Mark AldersonMAMark Alderson
- Suresh S. KerwarSKSuresh S. Kerwar
- Dauphine S. TorraneeDTDauphine S. Torranee
- Carol Otten-EvansCOCarol Otten-Evans
- Teresa GreenstreetTGTeresa Greenstreet
- Kumudini WeerawarnaKWKumudini Weerawarna
- Shirley R. KronheimSKShirley R. Kronheim
- Melissa PetersenMPMelissa Petersen
- 1 July 1994
- journal article
- Published by Springer Nature in Nature
- Vol. 370 (6486) , 218-220
Abstract
Tumour necrosis factor (tumour necrosis factor-alpha/cachectin) plays a critical role in certain physiological defensive responses but causes severe damage to the host organism when produced in excess. There are two forms of tumour necrosis factor, a type II membrane protein of relative molecular mass 26,000 (26K) and a soluble, 17K form generated from the cell-bound protein by proteolytic cleavage. The two forms of tumour necrosis factor and lymphotoxin-alpha (tumour necrosis factor-beta/lymphotoxin), a related protein, have similar but apparently not identical biological activities. A therapeutic agent which inhibited the release of tumour necrosis factor, but did not reduce the cell-associated activity or the level of lymphotoxin-alpha, might preserve the benefits of these cytokines while preventing tumour necrosis factor-induced damage. Here we describe a potent inhibitor of tumour necrosis factor processing and report that it protects mice from a lethal dose of endotoxin.Keywords
This publication has 23 references indexed in Scilit:
- Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorEuropean Journal of Immunology, 1993
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethalityEuropean Journal of Immunology, 1991
- Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?Trends in Pharmacological Sciences, 1990
- Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.Journal of Cell Biology, 1988
- Cloning, sequence and expression of bovine interleukin 1α and interleukin 1β complementary DNAsMolecular Immunology, 1988
- A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNFCell, 1988
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.Journal of Experimental Medicine, 1987
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- A simple and rapid method for the preparation of plasma membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983